BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 288 filers reported holding BLUEPRINT MEDICINES CORP in Q3 2021. The put-call ratio across all filers is 0.49 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $328,087 | -19.4% | 6,533 | +1.5% | 0.00% | – |
| Q2 2023 | $406,882 | +37.3% | 6,438 | -2.3% | 0.00% | – |
| Q1 2023 | $296,349 | +2.9% | 6,587 | +0.2% | 0.00% | – |
| Q4 2022 | $288,007 | -75.8% | 6,574 | -63.6% | 0.00% | -100.0% |
| Q3 2022 | $1,190,000 | +260.6% | 18,064 | +176.7% | 0.00% | – |
| Q2 2022 | $330,000 | -21.4% | 6,529 | -9.4% | 0.00% | – |
| Q1 2022 | $420,000 | -99.0% | 7,203 | -98.2% | 0.00% | -100.0% |
| Q4 2021 | $42,871,000 | +5756.7% | 400,242 | +5523.0% | 0.04% | +3800.0% |
| Q3 2021 | $732,000 | -98.4% | 7,118 | -98.7% | 0.00% | -97.8% |
| Q2 2021 | $46,482,000 | +3.3% | 528,454 | +14.2% | 0.04% | -2.2% |
| Q1 2021 | $44,984,000 | -17.2% | 462,657 | -4.5% | 0.05% | -24.6% |
| Q4 2020 | $54,336,000 | -5.2% | 484,498 | -21.7% | 0.06% | -17.6% |
| Q3 2020 | $57,325,000 | +30.2% | 618,401 | +9.5% | 0.07% | +23.3% |
| Q2 2020 | $44,033,000 | -43.3% | 564,521 | -57.5% | 0.06% | -7.7% |
| Q1 2020 | $77,676,000 | +72.8% | 1,328,242 | +136.7% | 0.06% | +18.2% |
| Q4 2019 | $44,956,000 | -4.2% | 561,182 | -12.2% | 0.06% | -8.3% |
| Q3 2019 | $46,941,000 | +1.2% | 638,912 | +29.9% | 0.06% | -36.2% |
| Q2 2019 | $46,402,000 | +22.7% | 491,902 | +4.2% | 0.09% | +9.3% |
| Q1 2019 | $37,806,000 | +49.2% | 472,282 | +0.5% | 0.09% | +34.4% |
| Q4 2018 | $25,347,000 | -28.6% | 470,162 | +3.4% | 0.06% | -12.3% |
| Q3 2018 | $35,482,000 | +27.2% | 454,562 | +3.4% | 0.07% | +23.7% |
| Q2 2018 | $27,898,000 | -35.1% | 439,482 | -6.3% | 0.06% | -37.2% |
| Q1 2018 | $42,989,000 | +19.4% | 468,802 | -1.8% | 0.09% | +23.7% |
| Q4 2017 | $35,998,000 | +23.6% | 477,362 | +14.2% | 0.08% | +16.9% |
| Q3 2017 | $29,113,000 | -2.1% | 417,862 | -28.8% | 0.06% | -7.1% |
| Q2 2017 | $29,746,000 | -1.8% | 587,052 | -22.5% | 0.07% | -2.8% |
| Q1 2017 | $30,301,000 | +63.6% | 757,702 | +14.8% | 0.07% | +53.2% |
| Q4 2016 | $18,517,000 | -23.5% | 660,150 | -19.0% | 0.05% | -30.9% |
| Q3 2016 | $24,217,000 | – | 815,410 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 423,012 | $41,129,000 | 7.43% |
| Eagle Health Investments LP | 133,163 | $12,947,000 | 5.08% |
| DAFNA Capital Management LLC | 207,911 | $20,215,000 | 4.80% |
| Casdin Capital, LLC | 1,550,000 | $150,707,000 | 4.49% |
| SIB LLC | 65,151 | $6,335,000 | 3.72% |
| CADIAN CAPITAL MANAGEMENT, LP | 913,702 | $88,839,000 | 3.29% |
| Integral Health Asset Management, LLC | 117,500 | $11,425,000 | 3.26% |
| Rock Springs Capital Management LP | 746,732 | $72,605,000 | 1.58% |
| Avidity Partners Management LP | 546,000 | $53,088,000 | 1.47% |
| Zebra Capital Management LLC | 12,698 | $1,235,000 | 1.36% |